Tryton

Tryton Medical is a medical device company based in Durham, North Carolina, with additional offices in The Netherlands. Founded in 2003 by Dr. Aaron V. Kaplan and Mr. H. Richard Davis, the company specializes in developing stent systems for treating bifurcation lesions in coronary artery disease. Their flagship product, the Tryton Side Branch Stent, features patented Tri-Zone technology that effectively addresses the challenges of bifurcation lesions, ensuring complete coverage of the affected areas. The Tryton Side Branch Stent has been validated through a large clinical trial involving over 700 patients across multiple countries, demonstrating its effectiveness in improving patient outcomes. Tryton Medical focuses on providing advanced solutions for interventional cardiology, serving healthcare providers, cardiologists, and medical institutions that perform percutaneous coronary interventions. The company has also formed strategic partnerships to enhance its distribution and market presence, reinforcing its commitment to advancing treatment options for complex coronary artery conditions.

• Employees 38
• Founded 2003
• Annual Revenue $9318000
• Total Funding $119267225